Bachem Japan K.K.

An innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides, Bachem draws on more than 50 years of experience to supply products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide. The company operates internationally with headquarters in Switzerland and locations across Europe, the US and Asia, and is listed on the SIX Swiss Exchange.